Dechert advised Roche and Foundation Medicine in their partnership. Roche and Foundation Medicine announced their partnership with Gustave Roussy, the leading cancer center in Europe, to...
You must be a Standard 1 Year member to access this content.
Fréget Glaser & Associés assisted the Novartis laboratory in its appeal against the Competition Authority’s decision. The Roche laboratory was advised by Dechert LLP. Novartis has...
You must be a Standard 1 Year member to access this content.
Dechert advised Chiesi Farmaceutici S.p.A. Gide Loyrette Nouel represented BNP Paribas. Amryt Pharma was advised by Cooley. Italian pharmaceutical company Chiesi Farmaceutici has signed a definitive agreement to acquire Amryt Pharma in...
You must be a Standard 1 Year member to access this content.
Deloitte | Taj et M&A Transaction Services and Dechert advised Mayoly Spindler, while Allen & Overy advised Ipsen. Weil Gotshal & Manges advised Caravelle and Capza...
You must be a Standard 1 Year member to access this content.
The Paul Hastings team advised the shareholders of Carso, while Dechert advised ArchiMed on the deal. ArchiMed, a leading investment firm exclusively dedicated to the healthcare...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Dechert, advised on the matter. Dechert advised Virbac Group with a team including Laurence Bary (Competition Law), Ermine Bolot (Picture – Corporate M&A), M?anie...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Allen & Overy, Dechert, advised on the matter. Allen & Overy advised Crédit Mutuel Equity with a team including Fr??ic Moreau (Corporate M&A), Romy...
You must be a Standard 1 Year member to access this content.
